Ads
related to: iqvia- About Us
Discover the Unique Approach
That Makes Genmab Different.
- Pipeline
Review our Pipeline and
See How We're Changing Treatment.
- Sign Up
Sign Up for Updates, News
and Much More.
- Approved Medicines
See the Approved Treatments
Using Our Antibody Science.
- About Us
Search results
Royalty Pharma to Acquire Royalty Interest in Sanofi's Frexalimab - Royalty Pharma (NASDAQ:RPRX)
Benzinga· 2 days agoRoyalty Pharma to highlight the strength of its development-stage pipeline on its first quarter of 2024 financial results call today at 8:00 a.m. NEW YORK, May 09, 2024 (GLOBE NEWSWIRE) -- Royalty ...